Recombinant nipah virus vaccines protect pigs against challenge

Journal of Virology

Volumn 80, Issue 16, 2006, Pages 7929-7938

  Weingartl, Hana M ^a,c   Berhane, Yohannes ^a   Caswell, Jeff L ^d   Loosmore, Sheena ^f   Audonnet, Jean Christophe ^g   Roth, James A ^e   Czub, Markus ^b,c  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

^e IOWA STATE UNIVERSITY   (United States)

^f Sanofi Pasteur   (Canada)

^g BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ARTICLE; ENCEPHALITIS; HUMAN; HUMAN CELL; IMMUNIZATION; NIPAH VIRUS; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; BRAIN; CANARYPOX VIRUS; CYTOKINES; GENETIC VECTORS; HENIPAVIRUS INFECTIONS; NIPAH VIRUS; RNA, VIRAL; SUS SCROFA; SWINE DISEASES; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

ANIMALIA; CANARYPOX VIRUS; NIPAH VIRUS; PARAMYXOVIRIDAE; SUS SCROFA;

EID: 33746837635     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00263-06     Document Type: Article

References (36)

1. AbuBakar, S., L.-Y. Chang, A. R. Mohd Ali, S. H. Sharifah, K. Yusoff, and Z. Zamrod. 2004. Isolation and molecular identification of Nipah virus from pigs. Emerg. Infect. Dis. 10:2228-2230.
2. Audonnet, J. C., J. Minke, and H. Poulet. 2005. Veterinary applications of the canarypox vaccine vector technology-recent developments for vaccines in domestic mammalian species, p. 133-140. In P. Moingeon (ed.), Vaccines: frontiers in design and development. Horizon Scientific Press, Norfolk, United Kingdom.
3. Belshe, R. B., C. Stevens, G. J. Gorse, S. Buchbinder, K. Weinhold, H. Sheppard, D. Stablein, S. Self, J. McNamara, S. Frey, J. Flores, J. L. Excler, M. Klein, R. E. Habib, A. M. Duliege, C. Harro, L. Corey, M. Reefer, M. Mulligan, P. Wright, C. Celum, F. Judson, K. Mayer, D. McKirnan, M. Marmor, G. Woody, and the National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group, and the H.I.V. Network for Prevention Trials (HIVNET). 2001. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J. Infect. Dis. 183:1343-1352.
4. Berhane, Y., J. D. Berry, C. Ranadheera, P. Marszal, B. Nicolas, X. Yuan, M. Czub, and H. Weingartl. 2006. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J. Virol. Methods 132:59-68.
5. Bossart, K. N., L.-F. Wang, M. N. Flora, K. B. Chua, S. K. Lam, B. T. Eaton, and C. C. Broder. 2002. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J. Virol. 76:11186-11198.
6. Chua, K. B. 2003. Nipah virus outbreak in Malaysia. J. Clin. Virol. 26:265-275.
7. Chua, K. B., C. L. Koh, P. S. Hooi, K. F. Wee, J. H. Khong, B. H. Chua, Y. P. Chan, M. E. Lim, and S. K. Lam. 2002. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 4:145-151.
8. Crouch, C. F., J. Daly, D. Hannant, J. Wilkins, and M. J. Francis. 2004. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an "American lineage" H3N8 virus. Vaccine 23:418-425.
9. Dahł, L., T. H. Jense, E. Gottschalck, P. Karlskov-Mortensen, T. D. Jensen, L. Nielsen, M. K. Andersen, Buckland T. F. Wild, and M. Blixenkrone-Moller. 2004. Immunization with plasmid DNA encoding the hemagglutinin and the nucleoprotein confers robust protection against lethal canine distemper virus challenge. Vaccine 22:3642-3648.
10. de Bryun, G., A. J. Rossini, Y.-L. Chiu, D. Holman, M. L. Elizaga, S. E. Frey, D. Burke, T. G. Evans, L. Corey, and M. C. Reefer. 2004. Safety profile of recombinant canarypox HIV vaccines. Vaccine 22:704-713.
11. de Swart, R. L., S. Yukseł, and A. D. M. E. Osterhaus. 2005. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J. Virol. 79:11547-11551.
12. Edlund Toulemonde, C., J. Daly, T. Sindle, P. M. Guigal, J. C. Audonnet, and J. M. Minke. 2005. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 156:367-371.
13. Esser M. T., R. D. Marchese, L. S. Kierstead, L. G. Tussey, F. Wang, N. Chirmule, and M. W. Washabaugh. 2003. Memory T cells and vaccines. Vaccine 21:419-430.
14. Ferrari, G., C. Berend, J. Ottinger, R. Dodge, J. Barlett, J. Tosso, D. Moody, J. Tartaglia, W. I. Cox, E. Paoletti, and K. J. Weinhold. 1997. Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infectious patients: implications for antigen-specific immunotherapy. Blood 90:2406-2416.
15. Giraudon, P., and T. F. Wild. 1985. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46-58.
16. Griffin, D. E. 2001. Measles virus, p. 1401-1441. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
17. Guillaume, V., H. Contamin, P. Loth, M.-C. Georges-Courbot, A. Lefeuvre, P. Marianneau, K. B. Chua, S. K. Lam, R. Buckland, V. Deubel, and T. F. Wild. 2004. Nipah virus: vaccination and passive protection studies in a hamster model. J. Virol. 78:834-840.
18. Guillaume, V., A. Lefeuvre, C. Faure, P. Marianneau, R. Buckland, S. K. Lam, T. F. Wild, and V. Deubel. 2004. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J. Virol. Methods 120:229-237.
19. Guillaume, V., H. Contamin, P. Loth, I. Grosjean, M. C. Georges Courbot, V. Deubel, R. Buckland, and T. F. Wild. 2006. Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J. Virol. 80:1972-1978.
20. Kríshnan, S., M. Halonen, and R. C. Welliver. 2004. Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 17:220-233.
21. Larsen, D. L., A. Karasin, F. Zuckermann, and C. W. Olsen. 2000. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet. Microbiol. 74:117-131.
22. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin. Microbiol. Rev. 9:532-562.
23. Malvoisin, E., and F. Wild. 1990. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 64:5160-5162.
24. Middleton, D., H. A. Westbury, C. J. Morrisy, B. M. van der Heide, G. M. Russell, M. A. Braun, and A. D. Hyatt. 2002. Experimental Nipah virus infection in pigs and cats. J. Comp. Pathol. 126:124-136.
25. Minke, J. M., L. Siger, K. Karaca, L. Austgen, P. Gordy, R. Bowen, R. W. Renshaw, S. Loosmore, J. C. Audonnet, and B. Norgren. 2004. Recombinant canarypox virus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 18:221-230.
26. Mohd Nor, M. N., C. H. Gan, and B. L. Ong. 2000. Nipah virus infection of pigs in peninsular Malaysia, Rev. Sci. Tech. 19:160-165.
27. Moss, W. J., M. O. Ota, and D. E. Griffin. 2004. Measles: immune suppression and immune responses. Int. J. Biochem. Cell Biol. 36:1380-1385.
28. Olszewska, W., Y. Suezer, G. Sutter, and P. J. M. Openshaw. 2004. Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins. Vaccine 23:215-221.
29. Plotkin, S. A., M. Cadoz, B. Meignier, C. Meric, O. Leroy, J. L. Excler, J. Tartaglia, E. Paoletti, E. Gonczol, and G. Chappuis. 1995. The safety and use of canarypox vectored vaccines. Dev. Biol. Stand. 84:165-170.
30. Premenko-Lanier, M., P. Rota, P. Rhodes, W. Bellini, and M. McChesney, 2004. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine. Vaccine 22:762-765.
31. Tamura, S., and T. Kurata. 2004. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57:236-247.
32. Taylor, J., B. Meignier, J. Tartaglia, B. Languet, J. VanderHoeven, G. Franchini, C. Trimarchi, and E. Paoletti. 1995. Biological and immunogenic properties of canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 13:539-549.
33. Wang L. F., B. H. Harcourt, M. Yu, A. Tamin, P. A. Rota, W. J. Bellini, and B. T. Eaton. 2001. Molecular biology of Hendra and Nipah viruses. Microbes Infect. 3:279-287.
34. Weingartl, H., S. Czub, J. Copps, Y. Berhane, D. Middleton, P. Marszal, J. Gren, G. Smith, S. Ganske, L. Manning, and M. Czub. 2005. Invasion of central nervous system in a porcine host by Nipah virus. J. Virol. 79:7528-7534.
35. Weingartl, H. M., M. A. Drebot, Z. Hubalek, J. Halouzka, M. Andonova, A. Dibernardo, C. Cottam-Birt, J. Larence, and P. Marszal. 2003. Comparison of assays for detection of West Nile virus antibodies in chicken sera. Can. J. Vet. Res. 67:128-132.
36. Wong, K. T., I. Grosjean, C. Brisson, B. Blanquier, M. Fevre-Montange, A. Bernard, P. Loth, M. C. Georges-Courbet, M. Chevallier, H. Akaoka, P. Marianneau, S. K. Lam, T. F. Wild, and V. Deubel. 2003. A golden hamster model for human acute Nipah virus infection. Am. J. Pathol. 163:2127-2137.